North America Contraceptives Market Insights Forecasts to 2032

• The North America Contraceptives Market Size was valued at USD 8.3 Billion in 2022.
• The Market is Growing at a CAGR of 7.56% from 2022 to 2032
• The North America Contraceptives Market Size is expected to reach USD 17.2 Billion by 2032.

The North America Contraceptives Market Size was valued at USD 8.3 Billion in 2022 and is expected to Grow to USD 17.2 Billion by 2032, at a CAGR of 7.56% during the forecast period 2022-2032.

Market Overview

Contraception is a method of preventing pregnancy that uses medications or a device. It is also known as a birth control mechanism or a fertility control mechanism. Contraceptive drugs or devices interfere with the natural process of sperm-ovum fertilization to avoid pregnancy. Contraceptives include medications such as oral contraceptive pills, injectable contraceptives, or topical contraceptives, as well as devices such as condoms, vaginal rings, and diaphragms. The growing emphasis on family planning and the avoidance of undesired pregnancy is projected to fuel market expansion.

Report Coverage

This research report categorizes the market of North America Contraceptives Market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the North America Contraceptives Market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segments of the North America Contraceptives Market.

Driving Factors

Increased usage of modern contraceptives and increased knowledge of sexual health and family planning among teenagers and the young population are significant factors driving market expansion in the United States. Furthermore, government initiatives have increased access to contraceptives, which aid in the prevention of unplanned births in teenagers. Also, the availability of generic and low-cost medications and technologies has increased the need for contraception among teens. Furthermore, nonhormonal contraceptives are becoming increasingly popular in the United States since they reduce the danger of unwanted effects related to hormonal imbalance in the body. Furthermore, as young women want to avoid the risks associated with hormonal contraception, demand for nonhormonal contraceptives is projected to rise. Nonhormonal vaginal rings, diaphragms, and novel condoms are likely to contribute to the expansion of the nonhormonal products category during the forecast period.

Market Segment

• In 2022, the devices segment is influencing the largest market share over the forecast period.

Based on the product, the North America contraceptives market is segmented into drugs {oral contraceptive pills, injectable contraceptives, topical contraceptives}, devices {Condoms [male, female], diaphragms, contraceptive sponges, vaginal rings, subdermal implants, intra-uterine devices [copper IUD, hormonal IUD]}. Among these segments, the devices segment dominates the largest market share during the forecast period due to the increased knowledge of sexually transmitted diseases (STDs), the greater success rate supplied by contraceptive devices, and the efficiency offered by condoms in avoiding infections, including HIV. The levonorgestrel intrauterine system (LNG IUD) and the copper T intrauterine device (IUD) are two of the most popular contraceptive devices. To prevent pregnancy, these devices are implanted in the uterus and release a little amount of progestin. The growing number of gynecologists who favor contraceptive devices due to improved clinical success is expected to increase market demand further

.

• In 2022, United States influenced the largest market share during the forecast period.

Based on the country, the North America Contraceptives Market is segmented United States, Canada, Mexico, and Rest of North America. Among these segments, the United States segment dominates the largest market share during the forecast period due to the rising utilization of contraception and adoption of supportive policies in the country. In addition, the availability of publicly funded family planning options through initiatives like Title X and Medicaid helps women to avoid around 2.2 million unplanned births each year. The adoption of the Affordable Care Act in all states, which offers a comprehensive package of contraceptive services, is critical to the development of high-quality contraceptive care.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the North America contraceptives market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Church & Dwight Co., Inc.
• Reckitt Benckiser Group Plc
• Veru, Inc.
• Organon Group of Companies
• Pfizer, Inc.
• Teva Pharmaceutical Industries Ltd.
• The Cooper Companies, Inc.
• Mayer Laboratories, Inc.
• Agile Therapeutics
• TherapeuticsmMD, Inc.
• Bayer Ag
• Afaxys, Inc.
• Mithra Pharmaceuticals
• Abbvie

Key Target Audience

• Contraceptives Market Players
• Contraceptives Investors
• Contraceptives End-users
• Contraceptives Government Authorities 
• Contraceptives Consulting and Research Firm
• Contraceptives Venture capitalists
• Contraceptives Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at global, regional, and country levels from 2022 to 2032. Spherical Insights has segmented the North America Contraceptives Market based on the below-mentioned segments:

North America Contraceptives Market, By Product

• Drugs
  • Oral Contraceptive Pills
  • Injectable Contraceptives
  • Topical Contraceptives

• Devices

• Condoms [Male, Female]
• Diaphragms,
• Contraceptive Sponges
• Vaginal Rings
• Subdermal Implants
• Intra-uterine Devices [Copper IUD, Hormonal IUD]}

North America Contraceptives Market, By Country

• United States
• Canada
• Mexico
• Rest of North America